LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTS

Provided By PR Newswire

Last update: Jan 4, 2023

--Announces Positive Animal PK Study Results of Insulin Aspart Versus US NovoLog^®--

--Analysis of Pivotal Trial Results of Insulin Glargine Nearly Completed, BLA Filing Timeline Slightly Delayed, But Potential Launch Timing Remains in Range--